chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had a little fatigue; Vague nausea that came in a couple of waves; Sore arm and sore muscles; Sore arm and sore muscles; Shingles; This is a spontaneous report from contactable other health care professional (patient). An 88-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: not reported, expiration date: not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Medical history included shingles, ongoing postherpetic neuralgia, non-hodgkin's lymphoma, chemotherapy, anemic. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 on an unspecified date as SINGLE for covid-19 immunization. On an unspecified date, patient stated Had a little fatigue, vague nausea that came in a couple of waves, sore arm and sore muscles (Painful arm) and (Muscle soreness), Shingles. Patient also stated she had a Shingles shot 5 years ago and had shingles 10 days after. She mentioned that she is still suffering from postherpetic neuralgia because of it and was advised not to get a shingles shot again. I am no longer anemic and have no other hematology issues. Patient mentioned that she got her second dose of vaccine about a week ago. She disconnected from the line while on hold but she experienced some little fatigue, a vague nausea which came in a couple of waves. She mentioned that she had a sore arm and some sore muscles for about two days and she mentions that she was okay right after that. The outcome of events was unknown.  Follow up(30Apr2021): New follow up information received from contactable nurse (patient) included: event information, relevant history information,   No follow-up attempts are needed, no further information expected.
Patient did not state he had any reaction. I will check in again on Thursday 9/10/20. This is per pharmacy protocol to file VAERS in the event of administering a vaccine out side of standing order and CDC guidelines.
Symptoms started to reappear on 27Apr2022; Symptoms started to reappear on 27Apr2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old male patient received BNT162b2 (BNT162B2), on 20Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ALBUTEROL HFA, start date: Jan2022, stop date: Apr2022; ADVAIR, start date: Jan2022, stop date: Apr2022; SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE], start date: Apr2022, stop date: Apr2022; SINGULAIR, start date: Jan2022, stop date: Apr2022; BUPROPION, start date: Jan2022, stop date: Apr2022. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Symptoms started to reappear on 27Apr2022". Therapeutic measures were taken as a result of suspected covid-19. Clinical course included  patient was taking any other medications/products within 2 weeks of starting COVID-19 treatment. Patient received Paxlovid as a treatment start date was19Apr2022 Treatment stop date was 23Apr2022. Patient previously received a COVID-19 Vaccine. It was reported symptoms started to reappear on 27Apr2022- congestion, fatigue, cough.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
The nurse administered the shot into the shoulder joint area  rather than the muscle. The shot was given above the deltoid and off center toward the back of the arm. There was intense pain upon administration. Pain continued through the evening, and it wasn't possible to sleep for much of the night. Pain during the day is less intense than at night. Lifting arm to change clothes or reach is extremely painful still at one week from injection. Pain radiates down to elbow and around to back. Sleeping is difficult as very few positions are pain free for the arm and turning is excruciating.
On March 6th I started to have severe cramping and subsequent diarrhea.  This continued through to March 7th.  I had to stay close to the bathroom in my bedroom during this period.  Prior to this on Dec 18th, 2020, I was diagnosed with C. Diff (clostridium difficile) - community acquired - no explanation as to source.  The first treatment with vancomycin failed and on Jan. 4, 2021, I was put on fidaxomicin (DIFICID).  This second treatment worked.  Thus, on March 7th, 2021 I was very afraid that I had a reoccurrence of C. Diff.  That is why I went to the Urgent Care on March 7th.  See below for tests.  It turned out I did NOT have C.Diff.  I was sent home with instructions to follow standard home care for diarrhea (BRAT diet, liquids).  And to consult my Primary Care physician if I did not improve.    By March 9th  or 10th, I was recovered.
Presented to ED w/ chief c/o COVID-19; admitted for COVID-19 pna and  hypoxemia; tx w/abx, remdesivir, O2, steroids, Vit-C, zinc. Weaned to RA. DC to SNF d/t hx TBI and needing more supportive care.
This spontaneous report was received from a other health professional referring to a [patient of unknown age and gender. Medical history and current conditions were not reported. On 10-MAR-2016, the patient was orally vaccinated with improperly stored dose of ROTATEQ (dose, frequency and indication were not reported; lot # L037924 with expiration date: 22-JUN-2017). Concomitant therapy was not reported. No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Rash all over body (a light rash); no other symptoms. Could also be from scented lotion - bath - first the rash occurred less than 24 hours after the vaccine.
I have experienced continued achiness in upper arm where the flu shot was administered.  Most noticeable when arm is elevated to shoulder height.  This feeling has been on-going since the date the vaccine was given.
Extremely dizzy and nauseous for about 36 hours. Headache for about 2 days. Symptoms started about and hour to an hour and a half after vaccine was administered. Treated with rest and fluids.
Quarter-size urticarial type lesion confluent with adjacent nickel sized lesion with some appearance. Both with pinpoint puncture wound in center. Warm to touch on left upper outer thigh on 8-28-08 --- DTaP an VARIVAX given in left thigh on 8.25.08
Patient stated after vaccine she felt flushed/dizzy/nauseous...states this is a common occurence after giving/having blood drawn due to needle phobia
Moderna COVID-19 Vaccine EUA lightheadedness began approximately 20 minutes after injection and lasted about 5 hours. Arm soreness started about three hours after the injection and is still onging 26 hours later.
AFTER VACCINE WAS ADMINISTERED PATIENT WAS SITTING IN THE WAITING AREA FOR THE RECCOMENDED AMOUNT OF TIME. WHEN SHE STARTED TO LEAVE THE PATIENT FELT LIKE SHE WAS GETTING A LUMP IN THE BACK OF HER THROAT. THE PATIENT WAS SCARED TO LEAVE AND DRIVE HOME JUST IN CASE SOMETHING ELSE WAS TO OCCUR. THE PATIENT WAS BROUGHT BACK INTO THE WAITING AREA AND BECAUSE OF HER CONCERN AND THE POSSIABILITY OF AN ALLERGIC REACTION SHE WAS ADVISED TO ALLOW THE AMBULANCE TO TRANSPORT HET TO THE HOSPITAL. SHE AGREED AND AHE WAS TRANSPORTED TO HOSPITAL.   I CALLED THE PATIENT TODAY AT 9:30 PM AND SHE STATED SHE WAS OK VIA TEXT.
I woke up in the middle of the night experiencing severe chills and shaking, my body was cold to the touch and I was unable to get warm. This lasted for several hours until finally fading away at around 12:30-1:00 PM on the same day (May 20th, 2021), at which point I developed a mild fever. I was unable to find any report of this side effect of severe chills/shaking on the vaccine's pamphlet that I got.
Tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high (High blood pressure).    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced COVID-19 (Tested positive for COVID). At the time of the report, COVID-19 (Tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, SARS-CoV-2 test: other (Positive) Tested positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication including  blood pressure medication was reported  No treatment medications were reported.
Body Shaking; After vaccination keeps deteriorating; I cannot drive; This spontaneous case was reported by an other and describes the occurrence of TREMOR (Body Shaking) and GENERAL PHYSICAL HEALTH DETERIORATION (After vaccination keeps deteriorating) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (Body Shaking) (seriousness criterion hospitalization), GENERAL PHYSICAL HEALTH DETERIORATION (After vaccination keeps deteriorating) (seriousness criterion hospitalization) and IMPAIRED DRIVING ABILITY (I cannot drive). The patient was hospitalized for 5 days due to GENERAL PHYSICAL HEALTH DETERIORATION and TREMOR. At the time of the report, TREMOR (Body Shaking), GENERAL PHYSICAL HEALTH DETERIORATION (After vaccination keeps deteriorating) and IMPAIRED DRIVING ABILITY (I cannot drive) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided by the reporter. No treatment information was provided by the reporter.  The patient reported that there was no definitive diagnosis about her condition after 5 days of stay at hospital. She had travelled 5600 miles to doctors trying to help. As of 01 May 2021, patient was healthy and was not on routine medicines. patient lost the job.  Very limited information regarding the events has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
Large local reaction in left deltoid area with hardened lump and soreness.  States soreness went up into her neck.  Had sinus congestion, no temp.
Pt reported redness about the size of a half dollar Tuesday night, told pt to take some BENADRYL and TYLENOL, patient ended up coming to the pharmacy on Wednesday and and increased in size.  Had not taken anything for it yet, but had increased in size to a length of about 6 inches and was warm to the touch.
Fever, loose stools, tired and clumsy.  Has about 15 chicken pox after receiving the chicken pox vaccine at her one year check up.
Developed swelling at the injection site along with red splotches, rash-like on arm down to elbow and other areas of body.  Also was very fatigued, slept more and had no energy for 3 weeks post vaccination.  Client phoned her provider to ask if she should receive the second dose of the shingles vaccine-provider stated yes.
After patient's required 15 minute wait time he reported a numbness and tingling at his injection site. No signs or symptoms of an allergic reaction were noted. Patient said it was like the injection hit a nerve.  Patient was instructed to monitor closely and report any other symptoms to us.
Approximately 1 week after my booster shot (3rd dose) I tested positive for COVID-19 and had the following symptoms: runny nose, scratchy throat, coughing, headache, fatigue, shortness of breath. For treatment, I took the prescriptions that were given to me before by my doctor (Albuterol Inhaler) and also took some Nyquil and Dayquil. It did help with my sleeping pattern and helped me with my cough. As of today 04/20/2022 some of my symptoms have gone away except for fatigue.
Headache, runny nose, sinusitis, fever, insomnia, malaise. Treatment Ibuprofen 200 mg.
8 days after injection, at injection site, arm red and itchy. Warm to touch.
Spoke with patient. He states he does have significant loss of movement and ROM. Pain has always been there since receiving vaccination however it is progressively worsening. Yesterday he noticed that he was having issues with moving arm and today it is even worse. He is applying heat and taking ibuprofen PRN but that is not doing much.
No additional AEs were reported; The healthcare worker reported that a patient received improperly stored vaccine.  The patient received only one dose but the healthcare worker did not specify which actual lot the patient received the vaccine.  No additional AEs were reported, no fu; This spontaneous report was received from a healthcare worker and refers to a 4-month-old patient of an unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.   On 31-AUG-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot number and expiration date were reported to be either W004504 and 16-JUN-2023 or W002562 (lot number confirmed to be valid) and 12-OCT-2023, respectively (the reporter did not specify which lot number was administered to the patient) for prophylaxis (dose, strength, and route of administration were not provided). The vaccine was improperly stored (temperature: 11.3 Celsius degrees, time frame: 34 minutes, no previous temperature excursion) (product storage error). No additional adverse event was reported (no adverse event).
broken cold chain until two weeks after the shipment arrived with no reported adverse event; after excursion, vaccine was administered with no reported adverse event; Initial information received on 19-Apr-2023 regarding an unsolicited valid non-serious case received from a physician.  This case involves Infant and unknown gender patient and reporter reported broken cold chain for haemophilus type B (HIB) (PRP/T) vaccine [ACT-HIB] until two weeks after the shipment arrived with no reported adverse event and after excursion, vaccine was administered with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect haemophilus type B (HIB) (PRP/T) vaccine Powder and solvent for solution for injection (lot number, strength, dosage, expiry date- not reported) via unknown route in unknown administration site for prophylactic vaccination. Information on the batch number was requested  Caller reported broken cold chain for haemophilus type B (HIB) (PRP/T) vaccine [ACT-HIB] until two weeks after the shipment arrived with no reported adverse event (product storage error) (unknown latency) and after excursion, vaccine was administered with no reported adverse event (poor quality product administered) (latency- same day).  Action taken was not applicable.  At time of reporting, the outcome was Unknown for both the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  2023SA124713:master case
LOSS OF APPETITE; FLU LIKE SYMPTOMS; COULD NOT SLEEP; SWEAT IT OUT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced loss of appetite, flu like symptoms, could not sleep, and sweat it out. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the loss of appetite, flu like symptoms, could not sleep and sweat it out was not reported. This report was non-serious.
swollen, her shoulder down to the elbow in the right arm; muscle in her arm is still inflamed and painful; muscle in her arm is still inflamed and painful; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INFLAMMATION (muscle in her arm is still inflamed and painful), INJECTION SITE PAIN (muscle in her arm is still inflamed and painful) and INJECTION SITE SWELLING (swollen, her shoulder down to the elbow in the right arm) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced INJECTION SITE INFLAMMATION (muscle in her arm is still inflamed and painful) and INJECTION SITE PAIN (muscle in her arm is still inflamed and painful). On an unknown date, the patient experienced INJECTION SITE SWELLING (swollen, her shoulder down to the elbow in the right arm). At the time of the report, INJECTION SITE INFLAMMATION (muscle in her arm is still inflamed and painful), INJECTION SITE PAIN (muscle in her arm is still inflamed and painful) and INJECTION SITE SWELLING (swollen, her shoulder down to the elbow in the right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No information regarding corrective treatment was reported by the patient.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: No specific follow-up information recorded.
40 year female received Pfizer-BioNTech COVID-19 Vaccine today  Patient reported prior h/o severe allergic reaction to influenza vaccine with eggs preservative.  She has received flu vaccine w/o egg w/o problem.  Due to her prior history of severe allergic reaction/ anaphylaxis to another vaccine, in this case flu vaccine with eggs, we should proceed with caution.  She was told we could defer vaccination until more information becomes available.  She opted to proceed with receiving Pfizer-BioNTech COVID-19 Vaccine and be observed for 30 minute observation period.  Patient developed throat tightening approximately 20 minutes after vaccination.  She received EpiPen within 1 minute of symptoms and was sent to ER immediately in wheelchair by nursing staff.  Patient was evaluated in ED and was hemodynamically stable.  She was given IV benadryl and was stable throughout observation
Patient is a 54 yo otherwise healthy man without coronary risk factors.  He received Pfizer 4/9/2021, 4/30/2021 and 12/1/2021.  About two weeks following his third shot patient developed dyspnea and fatigue.  He was admitted to hospital on 12/21 and a cardiac catheterization revealed clean coronaries but a depressed EF of 25-30%, diagnosing him with new-onset heart failure.  He required an IABP for inotropic support and a temporary pacemaker.  His viral panel on 12/21 was negative.  12/22 heart muscle biopsy demonstrated lymphocytic infiltration consistent with myocarditis.  Patient's condition improved with management, his IABP and temporary pacemaker were removed and he was discharged to home on 12/25 with heart failure medications.
1 hour after vaccination of Anthrax with presented burning chest/abdomen with nausea, skin red, warm, shaking.  "Severe" epigastric pain which changed to burning in abdomen.  Transported via ambulance to hospital.
intermittent appearance of erythematous papular rashes over the back of the neck/ shoulder, left arm and trunk in the last  6 weeks, first episode occurred 1 day after MMR,Pentacel ( L thigh), varicella (R thigh), significantly improved after antihistamine, total of 4 episodes.
I received the vaccine at 7:15 am, at approximately 10 am i became slightly lightheaded , so i had a soda. Through out the afternoon my hands started to become numb starting at the fingertips and working up to my hands, By 5 pm , both my hands were completely numb. I took Benadryl , Claritin and a pepcid OTC and they did nothing to help but made me sleep . I went to bed. I did not have any respiratiry symptoms. throughout the night i had multiple bouts of diarrhea and my hands cont to be numb. My cons cont to be numb t/o the day on Thurs 11/2 and inter 11/3, ending sometime in the afternoon 11/3. I did go to employee health on friday 11/3. At no time did the numbness ascend past my hands. I did contact my PCP also.  Of note, my mother had Guillian Barre when she was 58 y/o
Information has been received from a nurse concerning a female patient between the ages of 9 and 12 who was vaccinated with a first dose of Gardasil. Within the first several days of being vaccinated, the patient experienced abdominal cramping. It was reported that the patient was pre-pubsecent and was not menstruating. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. This is one of two reports from the same source. Additional information has been requested.
Swollen lymph nodes across right side of body. Lymph nodes of shoulder, chest and traps were swollen and body movement was severely restricted due to these swollen lymph nodes. I only got  one of the vaccines. Did not get the second one.
induration; redness; This case was reported by a other health professional via sales rep and described the occurrence of induration in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced induration and erythema. On an unknown date, the outcome of the induration and erythema were unknown.   It was unknown if the reporter considered the induration and erythema to be related to Shingrix.  Additional details were provided as follows: The reporter was a medical assistant. The age at vaccination was reported. The patient had redness and induration after receiving a dose of Shingrix vaccine. The reporter did not consent to follow up.
Patient wanted a high-dose fluzone shot, accidentally gave regular fluzone quadrivalent dosage.  No adverse side effects reported.
Patient experienced 'Covid arm.' It was reported to the pharmacy 5 days after the vaccination.  She complained of a warm, hard, painful and itchy arm on the side the vaccine was administered.  The redness seemed to spread some, but was overall improving.  She did try a muscle rub that helped with the pain.  She was going to try Benadryl to see if that improved it.